XPhos Pd G1
CAS: 1028206-56-5
Ref. 3D-FX64703
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado |
Informação sobre produto
Nome:
XPhos Pd G1
Produto Controlado
Sinónimos:
- Palladium, [2-(2-aminoethyl)phenyl]chloro-, compd. with dicyclohexyl[2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine (1:1)
- (2-Dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2-(2-aminoethyl)phenyl]palladium(ii) chloride
- Chloro(2-Dicyclohexylphosphino-2',4',6'-Triisopropyl-1,1'-Biphenyl)[2-(2-Aminoethyl)Phenyl]Palladium(Ii)
- Chloro(2-dicyclohexylphosphino-2',4',6'-tri-i-propyl-1,1'-biphenyl)[2-(2-aminoethyl)phenyl]palladium(II)methyl-t-butylether adduct
- XPhos Palladacycle
Descrição:
XPhos Pd G1 is a compound that has been synthesized for the treatment of neuroinflammatory, autoimmune, cardiovascular, and cancer disorders. This drug also acts as a nociceptive agent and has been shown to be effective in treating inflammatory pain. XPhos Pd G1 is an insoluble solid that can be prepared by cross-coupling reactions of imidazole derivatives with dioxane. It has been shown to have anti-infectious properties against bacteria and viruses including influenza A, respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and hepatitis B. XPhos Pd G1 also has metabolic effects on the body by reducing levels of pyridine compounds and increasing pyrazolyl concentrations in the blood stream.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
842.22 g/mol
Fórmula:
C41H59CINPPd
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
